UEFISCDI MelanoDet

MelanoDet “Melanomas Detection using Multispectral Imaging”, owner National University of Science and Technology Politehnica Bucharest, partner AIDE SANTE Medical Center, funded by UEFISCDI, Demonstration experimental project, grant PN-IV-P7-7.1-PED-2024-1873, agreement 61PED/2025 (budget 150k Eur, 2025-2026).

Objectives

The projects main objective is to improve patient’s quality of life through a more precise melanoma diagnosis in Romania and worldwide by following four steps: (1) Design and construction of the multispectral image acquisition system; (2) Acquisition of multispectral data for support in the clinical use of dermatologists; (3) Geometric alignment of multispectral images for a specific lesion; (4) Implementation of a software package to return a risk score. The algorithms will use techniques based on convolutional networks for the approach based on multispectral static images and techniques based on recurrent neural networks for the approach that includes the temporal component. Through its objectives, MelanoDet proposes the implementation of a system with technological maturity TRL2 that it aims to bring to TRL4 with scientific, technological and social impact. The projects’ main and secondary goals will focus on bringing added value to the area of healthcare domain, by working on completing the following: (1) Developing an interactive body-scan acquisition tool to guide the clinician to monitor a specific lesion; (2) The completion of a fully developed, tested and validated MelanoDet system, in the form of the Multispectral System for melanoma assessment; (3) Testing and validation of MelanoDet in a complete acquisition workflow of cross-functional team members; (4) The success of the real-life implementation in hospital will be also validated first in the scientific community by publishing the research results in top–level impact factors journals/conferences addressed by WP6 in section B2.3; (5) Multi- modal annotated nevi meta-database including a study of 500 clinical cases and (6) MelanoDet patent proposal will be defined once the setup and methodology will be finalized.